Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tuulia Vallius, M.D., Ph.D.

Concepts (71)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms, Glandular and Epithelial320174881.120 Why?
Ovarian Neoplasms6202449030.640 Why?
CA-125 Antigen220172810.510 Why?
Fluorodeoxyglucose F183201820280.430 Why?
Tumor Burden1201819030.390 Why?
Proteins2201760010.360 Why?
Radiopharmaceuticals2201727020.320 Why?
Neoadjuvant Therapy2201829020.320 Why?
Single-Cell Analysis3202425380.230 Why?
Antineoplastic Combined Chemotherapy Protocols32020118720.200 Why?
Quality Control120248350.190 Why?
Software2202444720.170 Why?
Myeloid Cells120248370.170 Why?
Chemotherapy, Adjuvant3202035520.160 Why?
Pyrimidinones120203850.150 Why?
Organoplatinum Compounds220184060.150 Why?
Cisplatin2202016560.140 Why?
Tumor Microenvironment3202439440.130 Why?
Receptors, Progesterone1202111590.130 Why?
Artifacts1202419040.130 Why?
Receptors, Estrogen1202122520.100 Why?
CD8-Positive T-Lymphocytes1202446480.090 Why?
Neoplasm Staging22017112170.090 Why?
Image Processing, Computer-Assisted2202489400.090 Why?
Receptor, erbB-21202125990.090 Why?
Positron-Emission Tomography2201865500.090 Why?
Postoperative Care1201714800.090 Why?
Pyrazoles1202020280.090 Why?
Cystadenocarcinoma, Serous120144800.090 Why?
Drug Resistance, Neoplasm2201953320.070 Why?
Regression Analysis1201563310.060 Why?
Prognosis22018299630.060 Why?
Aged, 80 and over32018595480.060 Why?
Research Design1201962100.060 Why?
Melanoma1202257020.050 Why?
Tomography, X-Ray Computed22018207410.050 Why?
Skin Neoplasms1202258590.050 Why?
Aged520201713190.050 Why?
Female920243966600.050 Why?
Models, Statistical1201550980.050 Why?
Humans1320247670400.040 Why?
Membrane Proteins1201778680.040 Why?
Platinum120192190.040 Why?
Ecosystem120224890.040 Why?
Retrospective Studies22018816590.040 Why?
Reproducibility of Results12015201690.040 Why?
Mammals1202211350.030 Why?
Models, Theoretical2201935610.030 Why?
Middle Aged420202232330.030 Why?
Prospective Studies22018548860.030 Why?
Taxoids120196650.030 Why?
Antineoplastic Agents12018136500.030 Why?
Lymphocytes, Tumor-Infiltrating1202111050.030 Why?
Cohort Studies12017417180.030 Why?
Cell Nucleus1202228750.030 Why?
Breast Neoplasms12021211780.030 Why?
Follow-Up Studies12014393170.030 Why?
Computational Biology1202435670.020 Why?
Drug Combinations1201820860.020 Why?
Protein-Tyrosine Kinases1202024280.020 Why?
Cell Cycle Proteins1202034400.020 Why?
Kaplan-Meier Estimate1201965130.020 Why?
Adult320202233170.020 Why?
Treatment Outcome12014652950.020 Why?
Cytokines1202274460.020 Why?
Computer Simulation1201962600.020 Why?
Clinical Trials as Topic1201980480.010 Why?
Apoptosis1201995130.010 Why?
Animals220241689650.010 Why?
Neoplasms12024223500.010 Why?
Young Adult12020599800.010 Why?
Vallius's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.